Delivery Order SPE2DR25D2104-SPE2DR26F3TTF
- Not listed
- The Defense Logistics Agency awarded a $3,081.23 delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This firm fixed-price contract, with a completion date of January 20, 2026, was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Epinephrine 0.3 mg auto-injectors (2-pack) with a ceiling value of $1,162.86 and a firm fixed-price structure. This order will be completed by January 13, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The award was made on a fully competitive, non-set-aside basis, demonstrating the contractor's capability to meet federal procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the procurement of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $5,507.40 and a completion date of January 6, 2026. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical supply transaction under the company's broader federal contracting portfolio with DLA. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $6,442.68 to AmerisourceBergen Drug Corp on January 27, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This firm fixed-price delivery order, with a completion date of January 28, 2026, represents a routine pharmaceutical procurement supporting military and federal healthcare operations. The award was competitively granted with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a $3,594.48 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with an ultimate completion date of January 13, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company, Cencora, Inc.'s, larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $1,797.24. This is a firm fixed-price delivery order with an ultimate completion date of February 5, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a $6,832.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract, which is scheduled for completion by January 9, 2026, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, valued at $2,738.77. This is a firm fixed-price delivery order with an ultimate completion date of December 5, 2025, and represents performance at the company's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded without any set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,094.04 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract is a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3TTFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,141.36 to AmerisourceBergen Drug Corp on January 15, 2026, for the procurement of Epinephrine 0.3 mg auto-injector two-packs. The contract is a firm fixed-price delivery order with an ultimate completion date of January 16, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not issued under any set-aside designation, indicating the contract was competitively awarded on a full and open basis. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 31, 2031. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs worldwide. The delivery order for epinephrine auto-injectors supports critical emergency medical readiness requirements across Defense Health Agency facilities and other federal military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 1/14/26 |